Page 355 - Vitamin D and Cancer
P. 355

342                                                           Index

            Retinoic acid receptor (RAR), 29, 35,    TRIP2/DRIP205. See Thyroid hormone
              148, 260                           receptor interactor 2
            Retinoid X receptor (RXR), 27, 30, 42, 154,   Tumor necrosis factor (TNF), 61, 102, 105,
              156, 157, 159, 196, 197, 206, 207, 212,   107, 130–131, 225, 226
              224, 232, 253, 254, 258, 268, 289
            Retinoid X receptor alpha (RXRa), 154
            Ribosomal s6 kinase (MAPK-activated protein   U
              kinase-1) (p90RSK ), 156, 157, 159  Ultraviolet (UV), 32, 36, 37, 41, 83, 89, 120,
                                                 121, 128, 156, 157, 193–196, 201, 203,
                                                 207–209, 211, 212, 226–228, 285, 297,
            S                                    298, 316–318, 322, 328, 332
            Seasonality, 75, 92, 106, 120, 121, 123, 185,   Ultraviolet B light (UV-B), 3, 36, 74–76, 79, 82,
              193, 202, 227, 281, 307, 308, 315, 317,   91, 106, 120, 128, 176, 183–184, 193, 195,
              318, 320, 322, 323                 207–209, 222, 228, 296, 315–317, 319, 320
            Serine/threonine-specific protein kinase B
              (AKT), 104, 152, 158, 159, 199, 209, 225,
              232, 259, 261, 262              V
            Silencing mediator of retinoid and thyroid   Vascular smooth muscle cells (VSMCs), 103,
              hormone receptors/Nuclear receptor   106–107
              co-repressor 2 (NCOR2/SMRT), 27, 28,   Vasculature, 100, 103, 107
              31, 40                          Vitamin D, 1–18, 73–92, 99–107, 115–132,
            Simian virus 40 (SV40), 280          143–163, 175–187, 191–212, 221–241,
            Skin cancer, 37, 74, 80, 88, 90, 176, 183, 187,   251–269, 279–290, 295–309, 315–323,
              191–212, 295–296, 316              327–335
            Solar UV radiation, 120, 195, 201  Vitamin D , 3, 15–16, 26, 32, 41, 107, 120,
                                                     3
            Specificity protein 1(Sp-1), 149     122, 123, 128, 176–178, 180–186,
            Squamous cell carcinoma (SCC), 17, 88, 103,   195–201, 257, 280, 283, 296–300, 304,
              104, 152–154, 195, 201, 202, 206, 209,   316, 322, 323, 328–329, 331
              228, 232                        Vitamin D analogues, 7, 16, 17, 104, 105, 150,
            SRA stem loop-interacting RNA-binding   177, 180, 181, 209, 211, 212, 231, 256,
              protein (SLIRP), 28                261–268, 283–285, 287–289
            Steroid receptor co-activator (SRC), 29, 30,   Vitamin D assay, 14, 103, 119, 120, 155, 161,
              154, 197, 198, 206, 233            177, 281, 297–302, 328–335
                                              Vitamin D  receptor (VDR), 2, 26, 62, 103,
                                                     3
                                                 147, 178, 193, 222, 253, 280, 296, 316, 334
            T                                 Vitamin D  response element (VDRE), 30, 41,
                                                     3
            T-cell transcription factor 4, 149   60, 148, 154, 156, 157, 159, 196–198, 206,
            Thyroid hormone receptor interactor 2   224, 225, 260–262, 268
              (TRIP2/DRIP205), 30
            Thyroid hormone receptor interactor 15
              (TRIP15/COPS2/Alien), 28        W
            Transforming growth factor beta (TGFb), 101,   Wild type (WT), 37, 56, 100, 104, 178, 179,
              283, 287                           183, 205, 207, 255, 267, 285, 287
            TRIP15/COPS2/Alien. See Thyroid hormone   Wingless-related MMTV integration site
              receptor interactor 15             (Wnt), 6, 33, 34, 39, 147–149
   350   351   352   353   354   355